Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study
出版年份 2023 全文链接
标题
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study
作者
关键词
-
出版物
INTEGRATIVE CANCER THERAPIES
Volume 22, Issue -, Pages 153473542211511
出版商
SAGE Publications
发表日期
2023-01-30
DOI
10.1177/15347354221151147
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer
- (2021) Zhiwei Xiao et al. MEDICINE
- Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma
- (2020) Hai-ying Wang et al. OncoTargets and Therapy
- Yiqi Chutan Tang Reduces Gefitinib‐Induced Drug Resistance in Non‐Small‐Cell Lung Cancer by Targeting Apoptosis and Autophagy
- (2019) Jue Zhang et al. CYTOMETRY PART A
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
- (2019) Kathryn C. Arbour et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)
- (2018) Baohui Han et al. BRITISH JOURNAL OF CANCER
- Anlotinib: First Global Approval
- (2018) Yahiya Y. Syed DRUGS
- Effects of Kanglaite Injection on Serum miRNA-21 in Patients with Advanced Lung Cancer
- (2018) Yue Wu et al. MEDICAL SCIENCE MONITOR
- Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
- (2018) Guoshuang Shen et al. Journal of Hematology & Oncology
- Angiogenesis Inhibitors in NSCLC
- (2017) Anna Manzo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review
- (2017) Youssef Ben Bouazza et al. LUNG CANCER
- Structural characterization and in vitro antitumor activity of an acidic polysaccharide from Angelica sinensis (Oliv.) Diels
- (2016) Yu Zhang et al. CARBOHYDRATE POLYMERS
- Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
- (2016) Andrew Bottomley et al. LANCET ONCOLOGY
- BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Caicun Zhou et al. JOURNAL OF CLINICAL ONCOLOGY
- Cantharidin inhibits angiogenesis by suppressing VEGF-induced JAK1/STAT3, ERK and AKT signaling pathways
- (2014) Ting Wang et al. ARCHIVES OF PHARMACAL RESEARCH
- Expression of prolyl 4-hydroxylase beta-polypeptide in non-small cell lung cancer treated with Chinese medicines
- (2014) Shu-mei Wang et al. Chinese Journal of Integrative Medicine
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
- (2009) Martin Reck et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Lung Cancer
- (2008) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search